Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.
Michele BorghesaniAnna ReniEleonora LauricellaAlice RossiViola MoscardaElena TrevisaniIrene TorresanTaymeyah Al-ToubahElisabetta FiloniClaudio LuchiniRiccardo De RobertisLuca LandoniAldo ScarpaCamillo PortaMichele MilellaJonathan StrosbergMauro CivesSara CingarliniPublished in: Journal of the National Comprehensive Cancer Network : JNCCN (2024)
mFOLFIRINOX shows antitumor activity against high-grade NENs. Well-designed, prospective clinical trials are needed to assess the efficacy of mFOLFIRINOX in both the neoadjuvant and metastatic settings.